➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Harvard Business School
Moodys
AstraZeneca
Medtronic
Colorcon
Mallinckrodt

Last Updated: August 15, 2020

DrugPatentWatch Database Preview

Chloroquine phosphate - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic sources for chloroquine phosphate and what is the scope of freedom to operate?

Chloroquine phosphate is the generic ingredient in three branded drugs marketed by Sanofi Aventis Us, Hikma Pharms, Impax Labs, Ipca Labs Ltd, Md Pharm, Natco Pharma Ltd, Purepac Pharm, Teva, and Watson Labs, and is included in fourteen NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty drug master file entries for chloroquine phosphate. Two suppliers are listed for this compound.

Recent Clinical Trials for chloroquine phosphate

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
CMN "20 de Noviembre"Phase 1
Royal College of Surgeons in Ireland - Medical University of BahrainPhase 2/Phase 3
Bahrain Defence Force Royal Medical Services, Military HospitalPhase 2/Phase 3

See all chloroquine phosphate clinical trials

Pharmacology for chloroquine phosphate
Drug ClassAntimalarial

US Patents and Regulatory Information for chloroquine phosphate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs CHLOROQUINE PHOSPHATE chloroquine phosphate TABLET;ORAL 087979-001 Dec 21, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Hikma Pharms CHLOROQUINE PHOSPHATE chloroquine phosphate TABLET;ORAL 083082-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Impax Labs CHLOROQUINE PHOSPHATE chloroquine phosphate TABLET;ORAL 040516-001 Aug 29, 2003 DISCN No No   Start Trial   Start Trial   Start Trial
Sanofi Aventis Us ARALEN PHOSPHATE W/ PRIMAQUINE PHOSPHATE chloroquine phosphate; primaquine phosphate TABLET;ORAL 014860-002 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Moodys
Mallinckrodt
Johnson and Johnson
Dow
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.